Trial Profile
A Single-Center, Randomized, Placebo- and Positive-Controlled, Parallel-Group Study of the Electrocardiographic Effects of Dalbavancin in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 May 2013
Price :
$35
*
At a glance
- Drugs Dalbavancin (Primary) ; Moxifloxacin
- Indications Bacterial infections; Diabetic foot ulcer; Osteomyelitis; Pneumonia; Skin and soft tissue infections
- Focus Adverse reactions